Overall | Complications | No complications | p value | |
---|---|---|---|---|
(n = 150) | (n = 86) | (n = 64) | ||
Patient characteristics | ||||
Male | 89 (59%) | 53 (62%) | 36 (56%) | 0.507 |
Age | 67 (15–84) | 67 (41–84) | 66 (15–82) | 0.496 |
BMI | 26 (18–42) | 26 (18–37) | 24 (19–42) | 0.046* |
ASA Class I | 1 (1%) | 1 (1%) | 0 (0%) | 1.0 |
II | 35 (23%) | 20 (23%) | 15 (23%) | |
III | 114 (76%) | 65 (76%) | 49 (77%) | |
Diabetes | 35 (23%) | 24 (28%) | 11 (17%) | 0.125 |
COPD | 12 (8%) | 9 (11%) | 3 (5%) | 0.237 |
Preoperative laboratory tests | ||||
Hemoglobin (g/l) | 130 (79–173) | 130 (82–173) | 129 (79–156) | 0.410 |
WCC (×109/l) | 7.5 (3.0–31.6) | 7.6 (4.1–31.6) | 7.0 (3.0–16.8) | 0.160 |
Platelets (×109/l) | 292 (21–744) | 293 (21–733) | 290 (139–744) | 0.605 |
Bilirubin (μmol/l) | 29 (5–405) | 35 (5–405) | 19 (6–352) | 0.109 |
Albumin (g/l) | 34 (13–49) | 34 (20–46) | 35 (13–49) | 0.045* |
Urea (mmol/l) | 5.3 (0.9–15.4) | 5.3 (0.9–12.2) | 5.2 (1.1–15.4) | 0.987 |
Creatinine (μmol/l) | 76 (10–241) | 79 (10–241) | 70 (28–186) | 0.036* |